These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 23580231)

  • 1. SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion.
    Chen XW; Wang H; Bajaj K; Zhang P; Meng ZX; Ma D; Bai Y; Liu HH; Adams E; Baines A; Yu G; Sartor MA; Zhang B; Yi Z; Lin J; Young SG; Schekman R; Ginsburg D
    Elife; 2013 Apr; 2():e00444. PubMed ID: 23580231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opening up new fronts in the fight against cholesterol.
    Debose-Boyd RA; Horton JD
    Elife; 2013 Apr; 2():e00663. PubMed ID: 23580362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of protein secretion by abrogating receptor-coat interactions during ER export.
    Gomez-Navarro N; Maldutyte J; Poljak K; Peak-Chew SY; Orme J; Bisnett BJ; Lamb CH; Boyce M; Gianni D; Miller EA
    Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2202080119. PubMed ID: 35901214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE.
    Ason B; van der Hoorn JW; Chan J; Lee E; Pieterman EJ; Nguyen KK; Di M; Shetterly S; Tang J; Yeh WC; Schwarz M; Jukema JW; Scott R; Wasserman SM; Princen HM; Jackson S
    J Lipid Res; 2014 Nov; 55(11):2370-9. PubMed ID: 25258384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation.
    Tavori H; Fan D; Blakemore JL; Yancey PG; Ding L; Linton MF; Fazio S
    Circulation; 2013 Jun; 127(24):2403-13. PubMed ID: 23690465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen has a unique SEC24 preference for efficient export from the endoplasmic reticulum.
    Lu CL; Ortmeier S; Brudvig J; Moretti T; Cain J; Boyadjiev SA; Weimer JM; Kim J
    Traffic; 2022 Jan; 23(1):81-93. PubMed ID: 34761479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the function and homeostasis of PCSK9: reciprocal interaction with LDLR and additional lipid effects.
    Tavori H; Rashid S; Fazio S
    Atherosclerosis; 2015 Feb; 238(2):264-70. PubMed ID: 25544176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kv1.3 contains an alternative C-terminal ER exit motif and is recruited into COPII vesicles by Sec24a.
    Spear JM; Koborssy DA; Schwartz AB; Johnson AJ; Audhya A; Fadool DA; Stagg SM
    BMC Biochem; 2015 Jul; 16():16. PubMed ID: 26156069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration.
    Zaid A; Roubtsova A; Essalmani R; Marcinkiewicz J; Chamberland A; Hamelin J; Tremblay M; Jacques H; Jin W; Davignon J; Seidah NG; Prat A
    Hepatology; 2008 Aug; 48(2):646-54. PubMed ID: 18666258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased APOE-containing HDL subfractions and cholesterol efflux capacity of serum in mice lacking Pcsk9.
    Choi S; Aljakna A; Srivastava U; Peterson BR; Deng B; Prat A; Korstanje R
    Lipids Health Dis; 2013 Jul; 12():112. PubMed ID: 23883163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A missense mutation in the Arabidopsis COPII coat protein Sec24A induces the formation of clusters of the endoplasmic reticulum and Golgi apparatus.
    Faso C; Chen YN; Tamura K; Held M; Zemelis S; Marti L; Saravanan R; Hummel E; Kung L; Miller E; Hawes C; Brandizzi F
    Plant Cell; 2009 Nov; 21(11):3655-71. PubMed ID: 19933202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9.
    van der Tuin SJ; Kühnast S; Berbée JF; Verschuren L; Pieterman EJ; Havekes LM; van der Hoorn JW; Rensen PC; Jukema JW; Princen HM; Willems van Dijk K; Wang Y
    J Lipid Res; 2015 Nov; 56(11):2085-93. PubMed ID: 26342106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression.
    Miranda MX; van Tits LJ; Lohmann C; Arsiwala T; Winnik S; Tailleux A; Stein S; Gomes AP; Suri V; Ellis JL; Lutz TA; Hottiger MO; Sinclair DA; Auwerx J; Schoonjans K; Staels B; Lüscher TF; Matter CM
    Eur Heart J; 2015 Jan; 36(1):51-9. PubMed ID: 24603306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways.
    Sasaki M; Terao Y; Ayaori M; Uto-Kondo H; Iizuka M; Yogo M; Hagisawa K; Takiguchi S; Yakushiji E; Nakaya K; Ogura M; Komatsu T; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1171-8. PubMed ID: 24675665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR.
    Nassoury N; Blasiole DA; Tebon Oler A; Benjannet S; Hamelin J; Poupon V; McPherson PS; Attie AD; Prat A; Seidah NG
    Traffic; 2007 Jun; 8(6):718-32. PubMed ID: 17461796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function and distribution of circulating human PCSK9 expressed extrahepatically in transgenic mice.
    Luo Y; Warren L; Xia D; Jensen H; Sand T; Petras S; Qin W; Miller KS; Hawkins J
    J Lipid Res; 2009 Aug; 50(8):1581-8. PubMed ID: 19060325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced VLDL clearance in Apoe(-/-)Npc1(-/-) mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels.
    Ishibashi M; Masson D; Westerterp M; Wang N; Sayers S; Li R; Welch CL; Tall AR
    J Lipid Res; 2010 Sep; 51(9):2655-63. PubMed ID: 20562239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vesicle-mediated export from the ER: COPII coat function and regulation.
    D'Arcangelo JG; Stahmer KR; Miller EA
    Biochim Biophys Acta; 2013 Nov; 1833(11):2464-72. PubMed ID: 23419775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRP94 Regulates Circulating Cholesterol Levels through Blockade of PCSK9-Induced LDLR Degradation.
    Poirier S; Mamarbachi M; Chen WT; Lee AS; Mayer G
    Cell Rep; 2015 Dec; 13(10):2064-71. PubMed ID: 26628375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B subviral envelope particles use the COPII machinery for intracellular transport via selective exploitation of Sec24A and Sec23B.
    Zeyen L; Döring T; Stieler JT; Prange R
    Cell Microbiol; 2020 Jun; 22(6):e13181. PubMed ID: 32017353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.